Search

Search Results
Results 51 - 60 of 170 for parkinson
  • Endep
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Endep intended for persons living in Australia.
  • Amitriptyline Viatris (formerly Amitriptyline Alphapharm)
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Amitriptyline Viatris (formerly Amitriptyline Alphapharm) intended for persons living in Australia.
  • Karvezide
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Clofen
    Drug - 8 Jun 2022
    Consumer Medicine Information (CMI) about Clofen intended for persons living in Australia.
  • Invega Hafyera
    Drug - 23 Feb 2022
    Consumer Medicine Information (CMI) about Invega Hafyera intended for persons living in Australia.
  • DBL Promethazine Hydrochloride
    Drug - 18 Jan 2022
    Consumer Medicine Information (CMI) about DBL Promethazine Hydrochloride intended for persons living in Australia.
  • Risperdal Tablets and Solution
    Drug - 27 Aug 2021
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution (Risperidone) intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Risperdal Consta
    Drug - 11 Aug 2020
    Consumer Medicine Information (CMI) about Risperdal Consta (Risperidone) intended for persons living in Australia.
  • Clopixol
    Drug - 28 Mar 2022
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback